Drug Trial Radar · NCT07502495
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Last checked: Nov 20, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
64
Actual
Start
Mar 27, 2026
Primary completion
Mar 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Biomea Fusion Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 31, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes who are not achieving glycemic targets despite antihyperglycemic medications.
Conditions
- Type 2 Diabetes
Interventions
icovamenib 100mgDrug
icovamenib 100mg
PlaceboDrug
Matching placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- To demonstrate that icovamenib 100 mg once daily for 12 weeks is superior to placebo for glycemic controlTime frame: 26 weeks
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Central Research Associates, LLC dba Flourish Research
Birmingham, Alabama
Hope Clinical Research
Canoga Park, California
Ark Clinical Research
Fountain Valley, California
Ark Clinical Research
Long Beach, California
Catalina Research Institute, LLC
Montclair, California
Paradigm Clinical Research Centers, LLC
San Diego, California
Southwest General Healthcare Center
Fort Myers, Florida
Panax Clinical Research
Miami Lakes, Florida
Clinical Site Partners, LLC dba Flourish Research
Winter Park, Florida
David Kavtaradze MD, Inc
Cordele, Georgia
Excel Clinical Research
Las Vegas, Nevada
Diabetes and Endocrinology Associates of Stark County
Canton, Ohio
Elligo Health Research, Inc.
Austin, Texas
Zenos Clinical Research
Dallas, Texas
Synergy Groups Medical
Houston, Texas
Epic Clinical Research
Lewisville, Texas
Synergy Group Medical LLC
Missouri City, Texas
Manassas Clinical Research Center
Manassas, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.